Protein phosphorylation on tyrosine residues is tightly controlled by protein tyrosine phosphatases (PTPs) at multiple levels: spatio-temporal expression, subcellular localization and post-translational modification. Structural and functional analysis of the PTP domains has provided insight into catalysis and regulatory mechanisms that control the enzymatic activity. Understanding the molecular basis of PTP regulation is of fundamental importance to dissect the pleiotropic effect of these enzymes in both health and disease. Here, we review recent insights into the regulation of receptorlike PTPs by extracellular ligands and into regulation by reversible oxidation that impairs catalysis directly. The physiological roles of PTPs are essential in homeostasis in eukaryotic cells and pertubation of their functional attributes causes different disease states. As an example, we discuss recent findings indicating how inappropriate oxidation of PTPs in cancer cells may contribute to cell transformation. On the other hand, PTPs from many pathogens are key virulence factors and manipulate signalling pathways in the host cells to promote invasion and survival of the microorganisms. This research area has received relatively little attention but has advanced remarkably. We review the structural features of pathogenic PTPs, their similarities and differences with eukaryotic PTPs, and the possible exploitation of this knowledge for therapeutic intervention.
Structures of PTPsAnalysis of protein tyrosine phosphatase (PTP) structures is not only important for understanding their function and regulation but also for identifying strategies for pharmacological modulation of PTP activity. Given the progress in establishing PTP deregulation in different pathologies such as cancer, PTPs deserve much attention as candidate drug targets. We focus on Cys-based PTPs [1] and discuss novel insights in PTP structure which may be important for pharmacological modulation, and emphasize novel findings and controversial issues for transmembrane (receptor-like) PTPs (RPTPs).Abbreviations AML, acute myeloid leukaemia; DUSP, dual specificity PTP; FLT3, Fms-like tyrosine kinase 3; FLT3 ⁄ ITD, internal tandem duplication of FLT3; LMWPTP, low molecular weight PTP; PDGF, platelet-defined growth factor; Prx, peroxiredoxin; PTP, protein tyrosine phosphatase; PTPLP, PTP-like phytase; ROS, reactive oxygen species; RPTP, transmembrane PTP; RTK, receptor tyrosine kinase; YopH, Yersinia outer protein H.